Organisation paid for research Program year 2020 Source: CMS Open Payments

Cancer Research Collaboration

Neither a doctor nor a teaching hospital

Research payments

$61,322

1 payment

Through program year 2020, Cancer Research Collaboration is reported as receiving $61,322 in research payments, across 1 payment.

By program year

1 row
Year Kind Amount Payments
2020 Research $61,322 1

Breakdown

Who paid Research payments · program year 2020
  1. Novartis Pharmaceuticals Corporation $61,322 1 payment
Studies the money was for Research payments · program year 2020
  1. A Phase II Multicenter Open Label Two Cohort Non Comparative Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant Or Letrozole in Patients With Pik3ca Mutant Hormone Receptor HR Positive Her2 Negative Advanced Breast Cancer Abc Who Have P $61,322 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record